Answers are grounded in this paper and cite their sources.
Donor KIR2DL1 allelic polymorphism affects recipient outcomes after allogeneic HSCT. These findings have substantial implications for prognostication and donor selection.
No takes yet. Share an insight, caveat, or question.
Bari et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: